U.S. Healthcare Services Stock News

NYSE:IONQ
NYSE:IONQTech

IonQ Stock Leads Quantum Computing Picks Worth A Closer Look

Quantum computing stocks sit at the crossroads of advanced research and real world problem solving, and that makes this screener especially interesting while central banks weigh inflation risks, bond yields press higher, and energy prices shape rate expectations. With policy signals mixed across the US, Europe, and Asia, many investors are looking for themes driven more by long term technological progress than by the next rate move. This Quantum Computing Stocks screener filters companies...
NasdaqGS:IRDM
NasdaqGS:IRDMTelecom

Iridium Communications (IRDM) Stock Faces Margin Compression As Net Profitability Weakens Narrative

Iridium Communications (IRDM) has reported Q2 2026 total revenue of US$225.2 million, with basic EPS of US$0.09 and net income of US$9.7 million, setting the tone for how investors interpret the latest quarter. The company has seen quarterly revenue move from US$216.9 million in Q2 2025 to US$225.2 million in Q2 2026, while basic EPS shifted from US$0.20 to US$0.09 over the same period, putting the spotlight firmly on how margins are holding up through this phase. See our full analysis for...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

Tariff Resistant US Small Cap Value Stocks Investors May Be Missing

With a fresh round of tariffs on the table, many investors are rethinking how exposed their portfolios really are to global trade tensions. The U.S. Small-Cap Value Stocks screener used for this article focuses on companies that lean more on domestic demand and have value characteristics that some investors look for when uncertainty around tariffs rises. This article breaks down 3 stocks from that group that appear to be more directly exposed to the latest trade headlines, explaining how the...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Could Be 33% Below Fair Value Following OTTAVA FDA Clearance

Johnson & Johnson (JNJ) has moved into U.S. soft tissue robotic surgery after the FDA granted De Novo authorization for its OTTAVA Robotic Surgical System, a table-integrated platform cleared for multiple general surgery procedures. See our latest analysis for Johnson & Johnson. Against this backdrop, Johnson & Johnson’s share price has climbed steadily, with a 30 day share price return of 8.44% and a year to date share price return of 25.04%. The 1 year total shareholder return of 56.73%...
NYSE:FAF
NYSE:FAFInsurance

First American Financial (FAF) Stock Faces Forecast Earnings Decline After Strong Q2 Net Margin

First American Financial (FAF) opened Q2 2026 with revenue of US$2,117.3 million and basic EPS of US$2.13, setting a clear marker for how the business is currently performing. The company has seen quarterly revenue move from US$1,582.3 million in Q1 2025 to US$2,117.3 million in Q2 2026, while basic EPS over the same stretch has ranged from US$0.71 in Q1 2025 to US$2.13 in the latest quarter. This leaves investors to weigh healthier trailing net margins against the sustainability of these...
NYSE:CDE
NYSE:CDEMetals and Mining

Gold Stocks For Higher Rates And Geopolitical Uncertainty

With inflation worries, higher-for-longer interest rates and ongoing geopolitical tension all in focus, many investors are looking for assets that can hold their ground when confidence in paper money is tested. Gold sits at the center of that discussion, and the Elite Gold Stocks screener is built to highlight companies with stronger balance sheets and lower production costs, which can be important in this type of market backdrop. In this article, you will see three stocks from the Elite Gold...
NYSE:PM
NYSE:PMTobacco

Does FDA’s ZYN Ruling And Mixed Q2 Results Change The Bull Case For Philip Morris (PM)?

In the past week, Philip Morris International reported second‑quarter 2026 results showing sales rising to US$11.19 billion from US$10.14 billion a year earlier, while net income eased to US$2.82 billion and diluted EPS from continuing operations slipped to US$1.80 from US$1.95. A key development was the U.S. FDA’s authorization of ZYN nicotine pouches as modified risk tobacco products, making ZYN the first nicotine pouch brand with this status and highlighting the growing regulatory...
NasdaqGS:CPB
NasdaqGS:CPBFood

Is Campbell’s (CPB) New Protein Soup Line a Real Shift in Its Wellness Strategy?

In July 2026, Campbell's Company launched Campbell's Protein Soups, a five-flavor line featuring slow-simmered bone broth, 20 grams of protein per can, and a green-label design, now rolling out nationwide at US$3.19. This launch targets the large group of Americans actively seeking more protein and balanced nutrition, aligning Campbell's traditional soup expertise with modern wellness-focused eating habits. We'll now explore how this protein-focused innovation, aimed at health-conscious...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Does NetApp’s AI Infrastructure Role at StructureCraft Reshape the Bull Case For NTAP?

In July 2026, NetApp filed a preliminary proxy urging shareholders to vote against a proposal to allow action by written consent, while also announcing that engineering and construction firm StructureCraft is using NetApp technology to build an AI-ready, centralized data infrastructure for global collaboration and large-scale design workloads. The StructureCraft collaboration highlights how NetApp’s storage and data platforms are being adopted as foundational infrastructure for custom AI...
NYSE:DVN
NYSE:DVNOil and Gas

Why Devon Energy (DVN) Is Up 5.3% After Oil-Driven Pre-Earnings Optimism And What's Next

In recent days, Devon Energy has drawn attention as investors react to pre-earnings expectations for higher earnings and revenue alongside sector-wide strength in energy stocks following a sharp rise in crude oil prices driven by geopolitical tensions in key shipping routes. What stands out is how growing optimism around Devon’s upcoming results is intersecting with shifting oil market conditions to reshape how investors view its cash flow resilience and exposure to commodity swings. Next,...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Stock Margins Near 20% Reinforce Bullish Profitability Narratives

Globe Life (GL) has posted fresh Q2 2026 results, with revenue at US$1.6b, basic EPS of US$3.71 and net income excluding extra items of US$287.7m, setting the tone for how the rest of the year might shape up. The company has seen revenue move from US$1.48b in Q2 2025 to US$1.6b in Q2 2026, while basic EPS over the same quarters shifted from US$3.09 to US$3.71, giving investors a clear read on the latest run rate and earnings power. Together with a trailing twelve month EPS of US$15.35 and net...
NasdaqGS:RELL
NasdaqGS:RELLElectronic

Richardson Electronics (RELL) Stock Faces Lofty P/E As Profitability Recovery Tests Bullish Narrative

Richardson Electronics (RELL) has capped FY 2026 with fourth quarter revenue of US$66.2 million and basic EPS of US$0.25, with trailing twelve month revenue at US$228.6 million and EPS of US$0.44 as the company settles into a newly profitable footing. Over the past six quarters, revenue has moved from US$51.9 million in Q4 FY 2025 to US$66.2 million in Q4 FY 2026, while quarterly EPS has ranged from a loss of US$0.14 in Q3 FY 2025 to a gain of US$0.25 in the latest quarter, giving investors a...
NYSE:CAAP
NYSE:CAAPInfrastructure

Corporación América Airports (CAAP) Reports Softer June Traffic, Is The Stock Still A Bargain?

Corporación América Airports (CAAP) shares are in focus after the company released June 2026 traffic figures, showing softer monthly passenger, cargo, and aircraft movement numbers but higher passenger volumes for the year to date. See our latest analysis for Corporación América Airports. At a share price of $25.02, Corporación América Airports has seen the 30 day share price return slip 4.39%, while the 1 year total shareholder return of 23.86% and 3 year total shareholder return of 84.51%...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Why Karooooo (KARO) Is Down 6.0% After Reaffirming Robust Fiscal 2027 Earnings Guidance – And What's Next

Karooooo Ltd. recently reported first-quarter 2026 results, with sales rising to ZAR 1,563.95 million and net income to ZAR 294.26 million, while reaffirming fiscal 2027 guidance for subscription revenue of ZAR 5,700 million to ZAR 6,000 million, operating margins of 27% to 30%, and earnings per share of ZAR 38.50 to ZAR 40.00. This combination of solid quarterly performance and reiterated guidance, supported by positive earnings estimate revisions, strengthens the company’s profile as a...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target Stock And 2 Defensive Dividend Picks For Rising Inflation

Geopolitical tension with Iran, higher oil at more than $100 a barrel, and US gas around $4.09 a gallon are feeding fresh inflation concerns and a bumpier path for markets ahead of the U.S. midterm elections. In this kind of backdrop, steady cash flows and reliable dividends can look appealing next to more cyclical stories. This article walks through three stocks from the U.S. Inflation Beneficiaries screener that are directly exposed to the current news flow, explaining why some investors...
NYSE:GPGI
NYSE:GPGITech

GPGI (GPGI) Faces Husky Lawsuits, Is The Stock Now Below Fair Value?

GPGI (GPGI) is under increased legal and market scrutiny after multiple securities class action lawsuits alleged that the Husky Technologies acquisition was misrepresented, with claims of overstated value, unrealistic targets, and fee driven motivations. See our latest analysis for GPGI. At a recent share price of $14.07, GPGI has seen selling pressure build, with the 7 day share price return down 5.63% and the year to date share price return down 24.64%, even as the 3 year total shareholder...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Medpace (MEDP) Stock Faces Margin Compression That Tests Bullish Growth Narratives

Medpace Holdings (MEDP) opened Q2 2026 with total revenue of US$707.3 million and basic EPS of US$4.31, while trailing twelve month figures show revenue of US$2.8 billion and EPS of US$17.39 alongside 17.5% earnings growth and 21.2% annual earnings compounding over five years. The company has seen revenue move from US$2.2 billion and EPS of US$13.83 on a trailing basis in Q2 2025 to the latest trailing tallies, with earnings growth of 8.5% and revenue growth of 6.7% flagged in forecasts,...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

Is Chefs' Warehouse (CHEF) A Bargain Or Fully Priced After Its 44% 90 Day Run?

Chefs' Warehouse (CHEF) is back in focus after a recent valuation check highlighted a rare split between models that estimate intrinsic value using discounted cash flows and more traditional, earnings-based yardsticks. See our latest analysis for Chefs' Warehouse. Chefs' Warehouse shares now trade at $94.46, with a 90 day share price return of 44.28% and a year to date share price return of 51.40%. The 5 year total shareholder return of 222.28% highlights longer term momentum that has...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Willdan Group (WLDN) Lands $31 Million Clean Energy Contract On An Undervalued Narrative

Willdan Group (WLDN) has drawn fresh investor attention after being selected by Encina Wastewater Authority for a $31 million design-build contract to deliver a renewable cogeneration project using biogas for on-site electricity. See our latest analysis for Willdan Group. At a share price of $73.35, Willdan Group’s recent contract win comes after a period where momentum has cooled, with the share price down 10.86% over the past month and 31.23% year to date. However, the 3 year total...
NYSE:CYH
NYSE:CYHHealthcare

Community Health Systems (CYH) Stock Faces One Off $352m Gain Questioning Earnings Quality

Community Health Systems (CYH) opened Q2 2026 with total revenue of US$2.8 billion and basic EPS of US$0.52, setting a clear marker against a current share price of US$2.78. Over the past six quarters, the company has seen quarterly revenue move between US$2.8 billion and US$3.2 billion while basic EPS has ranged from a loss of US$3.68 per share on a trailing 12 month basis in early 2025 to a trailing 12 month EPS of US$1.87 in Q2 2026. For investors, the key question now is how durable those...
NYSE:STC
NYSE:STCInsurance

Stewart Information Services (STC) Stock Sees Revenue Jump While Combined Ratio Pressures Narrative

Stewart Information Services (STC) has posted its Q2 2026 numbers with total revenue of US$899.2 million, basic EPS of about US$1.21 and net income of US$37.2 million. The trailing twelve months show revenue of US$3.3 billion, EPS of about US$4.60 and net income of US$134.7 million. The company has seen quarterly revenue move from US$722.2 million in Q2 2025 to US$899.2 million in Q2 2026, and basic EPS move from about US$1.13 to about US$1.21 over the same period. This sets up a results...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Ally Financial (ALLY) Stock Faces Bullish Narratives As 16.8% Net Margin Reshapes Earnings Story

Ally Financial (ALLY) has put solid numbers on the board for Q2 2026, with revenue of US$2.1 billion, basic EPS of US$1.19 and net income of US$367 million, set against a trailing 12 month EPS of US$4.29 on revenue of US$7.9 billion and net income of US$1.33 billion, alongside reported earnings growth of 310.2% over the past year. Over recent quarters the company has seen revenue move from US$1.59 billion in Q1 2025 to US$2.13 billion in Q2 2026, while quarterly basic EPS shifted from a loss...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

Interactive Brokers (IBKR) Stock Faces Margin Expansion Test After Q2 2026 Earnings Results

Interactive Brokers Group (IBKR) has just posted Q2 2026 results with revenue of US$1.9b, basic EPS of US$0.70 and net income of US$312 million, setting the tone for how investors assess the latest quarter. Over recent periods the company has seen quarterly revenue move from US$1.53b in Q2 2025 to US$1.88b in Q2 2026, while basic EPS has tracked from US$0.51 to US$0.70 over the same quarters, providing a clearer view of how the income statement is scaling. With trailing twelve month net...
NYSE:UPS
NYSE:UPSLogistics

UPS (UPS) Stock Looks Reasonable As Shares Stay Down 28%

United Parcel Service has climbed 18.9% over the past year but is still down 27.9% over three years, while valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both point to the stock trading below what its cash flows may justify. That sets up a clear tension between a recovering share price and indicators that still suggest potential undervaluation. The share price decline of 27.9% over three years means long-term holders are still under water,...